UNK MAMMARY IMPLANT
Report
- Report Number
- 9617229-2020-22864
- Event Type
- Injury
- Date Received
- January 6, 2021
- Date of Event
- August 21, 2019
- Report Date
- January 6, 2021
- Manufacturer
- ALLERGAN (COSTA RICA)
- Product Code
- FWM
- PMA / PMN Number
- P990074
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IS
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
UPON FURTHER REVIEW, THIS REPORT IS A DUPLICATE OF MRN 2024601-2011-00102. ANY ADDITIONAL INFORMATION RECEIVED WILL BE REPORTED UNDER MRN 2024601-2011-00102.
UPON FURTHER REVIEW, THIS REPORT IS A DUPLICATE OF MRN 2024601-2011-00102. ANY ADDITIONAL INFORMATION RECEIVED WILL BE REPORTED UNDER MRN 2024601-2011-00102.
ARTICLE CITATION: FAT GRAFTING AFTER IMPLANT REMOVAL DUE TO ANAPLASTIC LARGE CELL LYMPHOMA MAY MIMIC RECURRENCE NIR BITTERMAN MD, PAULA SIMOVIZ MD, TAMAR TADMOR MD, LIHI TZUR MD, NOAM CALDERON MD, AND OHAD BEN-NUN MD. THE EVENTS OF LYMPHOMA - ALCL- SUSPECTED, SEROMA - LATE, AND LUMP/NODULE, ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: LYMPHOMA-ALCL-SUSPECTED, SEROMA-LATE AND LUMP/NODULE.
JOURNAL ARTICLE: "FAT GRAFTING AFTER IMPLANT REMOVAL DUE TO ANAPLASTIC LARGE CELL LYMPHOMA MAY MIMIC RECURRENCE." THE ARTICLE REPORTS A PATIENT DIAGNOSED WITH BIA-ALCL. THE PATIENT PRESENTED WITH ¿SEROMA AND A MASS¿ AND WAS TREATED WITH ¿CHEMOTHERAPY¿.THE EFFECT SIDE HAS NOT BEEN PROVIDED. AFFECTED SIDE AND DEVICE REMOVAL STATUS UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 21361 | UNK MAMMARY IMPLANT | PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE | FWM | ALLERGAN (COSTA RICA) | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Required Intervention |